Cyclobutane derivatives as potent NK1 selective antagonists

  • Michelle Laci Wrobleski
  • , Gregory A. Reichard
  • , Sunil Paliwal
  • , Sapna Shah
  • , Hon Chung Tsui
  • , Ruth A. Duffy
  • , Jean E. Lachowicz
  • , Cynthia A. Morgan
  • , Geoffrey B. Varty
  • , Neng Yang Shih

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Abstract

A series of novel cyclobutane derivatives as potent and selective NK1 receptor antagonists is described. Several compounds in this series exhibited high in vitro binding affinity (Ki {less-than or slanted equal to} 1 nM), and potent inhibition of central NK1 receptor following oral administration. Syntheses of these compounds are also described herein.

Original languageEnglish
Pages (from-to)3859-3863
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume16
Issue number14
DOIs
StatePublished - 15 Jul 2006

Keywords

  • CNS penetration
  • Cyclobutane
  • NK antagonist
  • Oral in vivo activity
  • Substance P

Fingerprint

Dive into the research topics of 'Cyclobutane derivatives as potent NK1 selective antagonists'. Together they form a unique fingerprint.

Cite this